U.K. government lifts ban on the use of locally sourced plasma

03/04/2021

In 1998, a ban on UK-sourced plasma was introduced in the UK in response to concerns over the spread of an infectious disease. Now, 23 years later, thousands of individuals who need and rely on plasma and plasma-derived therapies will be able to benefit from treatments made from UK-sourced plasma, as the government lifts the ban. By lifting the ban, individuals can begin to donate plasma to be used for plasma-derived treatments. 

The Health Minister Lord Bethell says "Following expert advice, I am pleased we are now able to lift this ban to help thousands of NHS (National Health Service) patients access these potentially lifesaving treatments as quickly as possible." 

Until this ban was lifted, the UK has been dependant on importing donated plasma from other countries, mainly the United States, in order to manufacture the treatments they needed. With the plasma shortage and the continually rising demand for plasma, it's critically important that we can reach as many donors as possible, in the U.S., the UK, and around the world.

Lifting the ban will help the UK's supply chain of plasma and improve its ability to quickly and regularly produce plasma-derived treatments. The government is also introducing a new condition to ensure that plasma collected in the UK is used first in the country and not exported elsewhere. 

"The move will also help England become self-sufficient and we will not have to rely only on imports from other countries, ensuring every NHS patient can always access the treatments they need," says Health Minister Lord Bethell. 

We hope that more of our friends in the UK will step into their roles as Plasma Heroes. Visit plasmahero.org for more information on plasma-derived therapy and how you can become a plasma hero.

Join the Plasma Hero online community

Subscribe to Plasma Hero to get important news and updates that include hero stories and ways to get involved!

Sign up

News & Updates

Get the latest information on plasma through our news and updates. Featuring: Scientific discoveries, plasma supply, industry-related coverage, policy and legislation, and more!

Those with alpha-1 antitrypsin deficiency depend on plasma donations

07/16/2024

Many rare, chronic conditions with no known cures, including alpha-1 antitrypsin deficiency, can be managed with augmentation therapy treatments made from donated plasma.
Read More

Increase plasma supply by harmonizing state regulations

06/11/2024

States with regulations exceeding FDA standards create barriers for plasma centers, donors, and patients.
Read More

Plasma is a vital weapon against tetanus and rabies

05/20/2024

While tetanus and rabies are fairly rare in the United States today, these deadly diseases still pose a major global health threat. However, plasma-derived antibody products play a crucial role in treating these illnesses around the world.
Read More

Congressional Plasma Caucus formed to address concerns of constituents

04/25/2024

Members of the congressional Plasma Caucus provide a venue to educate legislators on important legislation to provide access to patients who rely on immunoglobulin (Ig) therapy.
Read More

Plasma demand is on the rise because of new patients and products

03/26/2024

The need for plasma is forecasted to increase since more patients are being diagnosed with current and newly discovered rare conditions as well as additional indications being approved for plasma medications.
Read More

Busting common plasma donation myths

02/21/2024

Misconceptions about plasma donation, such as that it is bad for your health, lead to undue misapprehensions.
Read More